Healthy adult
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Twenty subjects are divided into two groups at each ten subjects as described bilow. 10 subjects whose fasting blood glucose levels are ranged from 110 mg/dl to less than 125 mg/dl .10 subject whose fasting blood glucose levels are ranged to less than 110 mg/dl. 2) Subjects whose BMI are from 20 kg/m2 to less than 28 kg/m2. 3) Subjects whose systolic blood pressure is 139 mmHg or less and diastolic blood pressure is 89 mmHg or less. 4) Subjects whose triglyceride is 50 mg/dl or more and 149 mg/dl or less. 5) Subjects who can make self-judgment and are voluntarily giving written informed consent.
Exclusion criteria
Exclusion criteria: 1) Subjects who take continuous medical treatment. 2) Subjects who are contracting heart disease, liver disease, kidney disease, digestive disease and allergy disease. 3) Subjects with serious infection 4) Subjects with smoking habit 5) Those whose amount of drinking on the 1st is more than 500 ml in beer conversion. 6) Subjects who are doing carbohydrates restricted diet now. 7) Subjects who participate in other clinical trials. 8) Subjects who are not eligible due to physician's judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood samples were collected before ingestion and 0.5,1,2,3,4 and 5 hours after ingestion.Urine samples were collected before ingestion and accumulation urine samples were pooled during the postprandial reriods for 5 hrs. Primary outcome is postprandial blood glucose | — |
Secondary
| Measure | Time frame |
|---|---|
| Key secondary outcomes are insulin, triglyceride and glucose-dependent insulinotropic polypeptide. | — |
Countries
Japan
Contacts
QOL RD Co.,Ltd. CRO Department Food Division